Michael W. Konstan

Also affiliated with Case Western Reserve University

MedicineSocial Sciences

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 20 papers. Top paper: “Evaluating assumptions of definition-based pulmonary exacerbation endpoints in cystic fibrosis clinical trials”.

Evaluating assumptions of definition-based pulmonary exacerbation endpoints in cystic fibrosis clinical trials

Journal of Cystic Fibrosis(2020)10.1016/j.jcf.2020.07.008

N/A

0.930DataRank · unranked

18 citations

N. Hamblett, Noah Simon, Joseph McIntosh, Michael W. Konstan, Donald R. VanDevanter

Impact of the Communities That HEAL Intervention on Buprenorphine-Waivered Practitioners and Buprenorphine Prescribing

JAMA Network Open(2024)10.1001/jamanetworkopen.2024.0132

N/A

0.642DataRank · unranked

6 citations

Denise C. Babineau, Erin B. Gibson, Charles Knott, Debbie M. Cheng, Jennifer Villani +35 more

Genomic heterogeneity underlies multidrug resistance in Pseudomonas aeruginosa: A population-level analysis beyond susceptibility testing

PLoS ONE(2022)10.1371/journal.pone.0265129

N/A

0.470DataRank · unranked

22 citations

Mohamad Yasmin, Jacquelynn Benjamino, Steven Marshall, Kailynn DeRonde, Nikhil Krishnan +17 more

Willingness of people with cystic fibrosis receiving elexacaftor/tezacaftor/ivacaftor (ETI) to participate in randomized modulator and inhaled antimicrobial clinical trials

Journal of Cystic Fibrosis(2023)10.1016/j.jcf.2023.04.007

N/A

0.347DataRank · unranked

5 citations

Edith T. Zemanick, Michael W. Konstan, Clement L. Ren, Katherine Odem‐Davis, I. Emerman +3 more

Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutation

UNC Libraries(2020)10.17615/fm1q-nk97

N/A

0DataRank · unranked

31 citations

Michael W. Konstan, Steven M. Rowe, Manfred Ballmann, Laurent Vernillet, Jordan Dunitz +25 more

Classifying Severity of Cystic Fibrosis Lung Disease Using Longitudinal Pulmonary Function Data

UNC Libraries(2020)10.17615/k1p7-pz80

N/A

0DataRank · unranked

0 citations

Mitchell L. Drumm, Michael W. Konstan, Mark Schluchter, James R. Yankaskas, Michael R. Knowles

Measuring the impact of CFTR modulation on sweat chloride in cystic fibrosis: Rationale and design of the CHEC-SC study

Journal of Cystic Fibrosis(2021)10.1016/j.jcf.2021.01.011

N/A

0DataRank · unranked

24 citations

Michael W. Konstan, Donald R. VanDevanter, Steven M. Rowe, JP Clancy, Katherine Odem‐Davis +3 more

Empire-CF study: A phase 2 clinical trial of leukotriene A4 hydrolase inhibitor acebilustat in adult subjects with cystic fibrosis

Journal of Cystic Fibrosis(2021)10.1016/j.jcf.2021.08.007

N/A

0DataRank · unranked

20 citations

Michael W. Konstan, Jennifer L. Taylor‐Cousar, Isabelle Fajac, Alex Horsley, Sivagurunathan Sutharsan +11 more

Rate of Lung Function Decline in People with Cystic Fibrosis Having a Residual Function Gene Mutation

Pulmonary Therapy(2022)10.1007/s41030-022-00202-y

N/A

0DataRank · unranked

4 citations

Michael W. Konstan, Edward F. McKone, Richard B. Moss, Barry Lubarsky, Ellison Suthoff +8 more

Advancing the pipeline of cystic fibrosis clinical trials: a new roadmap with a global trial network perspective

The Lancet Respiratory Medicine(2023)10.1016/s2213-2600(23)00297-7

N/A

0DataRank · unranked

33 citations

John P. Clancy, Raksha Jain, Scott H. Donaldson, Isabelle Fajac, Christopher H. Goss +21 more

Longitudinal bacterial prevalence in cystic fibrosis airways: Fact and artifact

Journal of Cystic Fibrosis(2023)10.1016/j.jcf.2023.09.011

N/A

0DataRank · unranked

15 citations

John J. LiPuma, Michael W. Konstan, Donald R. VanDevanter

Heterogeneity of CFTR modulator-induced sweat chloride concentrations in people with cystic fibrosis

Journal of Cystic Fibrosis(2024)10.1016/j.jcf.2024.02.001

N/A

0DataRank · unranked

26 citations

I. Emerman, Morgan McCreary, N. Mayer-Hamblett, Mark N. Warden, Katherine Odem‐Davis +5 more

Effects of the Communities that Heal (CTH) intervention on perceived opioid-related community stigma in the HEALing Communities Study: results of a multi-site, community-level, cluster-randomized trial

The Lancet Regional Health - Americas(2024)10.1016/j.lana.2024.100710

N/A

0DataRank · unranked

15 citations

Hannah K. Knudsen, Daniel M. Walker, Deborah Chassler, Karsten Lunze, Philip M. Westgate +28 more

Prospective Cohort Study of Fentanyl Test Strip Use and Distribution in Three States: The Stay Safe Study Protocol and Implementation Recommendations for Researchers

Research Square(2024)10.21203/rs.3.rs-4870101/v1

N/A

0DataRank · unranked

0 citations

Denise C. Babineau, Rachel Caspar, James L. David, Megan E. Dzurec, Nabila El–Bassel +21 more

Fentanyl Test Strip Use and Overdose Risk Reduction Behaviors Among People Who Use Drugs

JAMA Network Open(2025)10.1001/jamanetworkopen.2025.10077

N/A

0DataRank · unranked

25 citations

Kitty H. Gelberg, Janet E. Childerhose, Denise C. Babineau, Redonna Chandler, James L. David +28 more

Reopening Schools Safely: The Case for Collaboration, Constructive Disruption of Pre-Coronavirus 2019 Expectations, and Creative Solutions

The Journal of Pediatrics(2020)10.1016/j.jpeds.2020.05.022

N/A

0DataRank · unranked

22 citations

Lisa M. Guay‐Woodford, Bruce R. Blazar, Scott R. Bowman, Carrie L. Byington, Jeffrey S. Dome +12 more

Overdose education and naloxone distribution in jails: Examining the impact of the Communities That HEAL intervention in 4 states

Health & Justice(2025)10.1186/s40352-025-00353-5

N/A

0DataRank · unranked

2 citations

Carrie B. Oser, Peter D. Friedmann, Nicole Mack, Peter Balvanz, Bridget Freisthler +38 more

Pseudomonas aeruginosa antimicrobial susceptibility test (AST) results and pulmonary exacerbation treatment responses in cystic fibrosis

Journal of Cystic Fibrosis(2020)10.1016/j.jcf.2020.05.008

N/A

0DataRank · unranked

13 citations

Sonya L. Heltshe, Jay B. Hilliard, Michael W. Konstan, Donald R. VanDevanter

Effect of VX-770 in Persons with Cystic Fibrosis and the G551D- CFTR Mutation

UNC Libraries(2020)10.17615/bbpq-c156

N/A

0DataRank · unranked

47 citations

Melissa A. Ashlock, Steven D. Freedman, Scott D. Sagel, Michael W. Konstan, Steven M. Rowe +21 more

Building global development strategies for cf therapeutics during a transitional cftr modulator era

Journal of Cystic Fibrosis(2020)10.1016/j.jcf.2020.05.011

N/A

0DataRank · unranked

31 citations

Silke van Koningsbruggen‐Rietschel, David P. Nichols, Donald R. VanDevanter, Jane C. Davies, T. Lee +20 more